¹Ì±¹ÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ½Ã¼ú À¯Çüº°, Á¦Ç° ¹üÀ§º°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
U.S. Electrophysiology Mapping And Ablation Devices Market Size, Share & Trends Analysis Report By Procedure Type (EP Ablation Procedures, Stand-Alone EP Diagnostic Procedures), By Product Coverage, And Segment Forecasts, 2025 - 2033
»óǰÄÚµå : 1790398
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,549,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,950 £Ü 6,954,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,764,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå ÇöȲ ¿ä¾à

¹Ì±¹ÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 104¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2033³â¿¡´Â 231¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â 8.05%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ì±¹ ³» Àü±â»ý¸®ÇÐ(EP) ¸ÅÇÎ ÀýÁ¦¼ú ±â±âÀÇ º¸±ÞÀº ½É¹æ¼¼µ¿ ¹× ±âŸ º¹ÀâÇÑ ºÎÁ¤¸Æ, ƯÈ÷ °í·ÉÈ­ ¹× °íÀ§Ç豺 ȯÀÚ¿¡¼­ ½É¹æ¼¼µ¿ ¹× ±âŸ ºÎÁ¤¸ÆÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÃßÁøµÇ°í ÀÖ½À´Ï´Ù.

¹Ì±¹ ³» ºñ¸¸À² Áõ°¡, °íÇ÷¾Ð, ´ç´¢º´ÀÇ À¯ÇàÀº ¼ö¼ú °Ç¼ö Áõ°¡¿¡ ±â¿©ÇÏ°í °í±Þ Áø´Ü ¹× Ä¡·á EP ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. CDC¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â 2030³â±îÁö ¾à 1,210¸¸ ¸íÀÌ ½É¹æ¼¼µ¿À» ¾ÎÀ» °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­ ºÎÁ¤¸Æ, ƯÈ÷ ½É¹æ¼¼µ¿ÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àü±â»ý¸®ÇÐ(EP) ¸ÅÇÎ ¹× ÀýÁ¦ ÀåÄ¡ÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

º´¿ø°ú Àü¹®¼¾ÅͰ¡ ½ÉÀ庴 ÇÁ·Î±×·¥À» È®´ëÇÔ¿¡ µû¶ó, º¸´Ù ºü¸£°í Á¤È®ÇÑ Áø´Ü°ú Ç¥ÀûÈ­µÈ Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. 202³â 3¿ù, Clinical Cardiology Àú³ÎÀº ¹Ì±¹¿¡¼­ 25³â°£ÀÇ ºÎÁ¤¸Æ °ü·Ã »ç¸ÁÀÚ ºÐ¼® °á°ú¸¦ ¹ßÇ¥Çϸ鼭 1999³âºÎÅÍ 2023³â±îÁö 35¼¼ ÀÌ»ó ¼ºÀÎÀÇ ºÎÁ¤¸ÆÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö°¡ 505¸¸ ¸íÀ̶ó°í º¸°íÇß½À´Ï´Ù. »ç¸Á·üÀº 1999³âºÎÅÍ 2009³â±îÁö °¨¼ÒÇß´Ù°¡ ÀÌÈÄ ²ÙÁØÈ÷ Áõ°¡ÇÏ´Ù°¡ 2021³â Äڷγª19 ÆÒµ¥¹Í ±â°£ µ¿¾È Á¤Á¡À» ÂïÀº ÈÄ ¼ÒÆø Ç϶ôÇß½À´Ï´Ù.

±â¼ú ¹ßÀüÀº ¿©ÀüÈ÷ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. 3D ¸ÅÇÎ ½Ã½ºÅÛ, ÆÞ½º Çʵå ÀýÁ¦ Ç÷§Æû, AI °¡ÀÌµå ³»ºñ°ÔÀÌ¼Ç µîÀÇ ±â¼ú Çõ½ÅÀ¸·Î Á¤È®µµ°¡ Çâ»óµÇ°í ½Ã¼ú À§ÇèÀÌ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϰí, Ä¡·á °á°ú¸¦ °³¼±Çϸç, °æÀïÀÌ Ä¡¿­ÇØÁö´Â Àü±â»ý¸®ÇÐÀû ȯ°æ¿¡¼­ ¿ìÀ§¸¦ Á¡ÇϰíÀÚ ÇÏ´Â ¹Ì±¹ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµé »çÀÌ¿¡¼­ Å« È£ÀÀÀ» ¾ò°í ÀÖ½À´Ï´Ù. 2025³â 6¿ù, Philips ¸Þµð»çÀÌÁî(Phillips Medisize)´Â °íÀü¾Ð, ´ÙÁß ÇÉ ¼öÀÇ Àü±â»ý¸®ÇÐ(EP) ¸ÅÇÎ ¹× ÀýÁ¦ Àåºñ¿¡ ÀûÇÕÇÑ ÀÇ·á¿ë Ä¿³ØÅÍÀÇ Ã¹ ¹øÂ° ºê·£µå ¶óÀÎÀÎ Å×¶óº¼Æ®(TheraVolt)¸¦ Ãâ½ÃÇÏ¿´½À´Ï´Ù. ÆÞ½º ÇÊµå ¼ÒÀÛ ¿ä¹ýÀ» Áö¿øÇϵµ·Ï ¼³°èµÈ TheraVolt´Â °í¹Ðµµ ÅëÇÕ°ú Ç÷§ÆûÀÇ À¯¿¬¼ºÀ» °®Ãá ¸ÂÃãÇü ¸ê±Õ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

¹Ì±¹ Àü¿ªÀÇ ÀÎ½Ä Á¦°í¿Í ½ºÅ©¸®´× ³ë·ÂÀ¸·Î EP ±â¼ú »ç¿ëÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. Áö¿ª ÀÇ·á ÇÁ·Î±×·¥, ÀÇ·á ½Ã½ºÅÛ ÁÖµµÀÇ ¾Æ¿ô¸®Ä¡, Àû±ØÀûÀÎ ¸®µë ¸ð´ÏÅ͸µÀº ºÎÁ¤¸ÆÀ» Á¶±â¿¡ ¹ß°ßÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇÕº´ÁõÀÌ ¹ß»ýÇϱâ Àü¿¡ Áø´ÜÀ» ¹Þ´Â ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó Áø´Ü ¹× Ä¡·á EP ½Ã¼ú°ú À̸¦ Áö¿øÇÏ´Â Àåºñ¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. 2025³â 7¿ù PCNA°¡ ¹ßÇ¥ÇÑ ¹é¼­´Â ¸Þ¸±·£µåÁÖ º¼Æ¼¸ð¾î¿¡¼­ ½É¹æ¼¼µ¿(AFib)°ú °íÇ÷¾ÐÀ» ´ë»óÀ¸·Î ÇÑ Áö¿ª ±â¹Ý ¼±º°°Ë»ç ÀÌ´Ï¼ÅÆ¼ºêÀÇ ¼º°ú¸¦ Æò°¡ÇÑ °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â ½É¹æ¼¼µ¿Àº Áõ»óÀÌ ÀϽÃÀûÀ̱⠶§¹®¿¡ ¿©ÀüÈ÷ Áø´ÜÀÌ Àß ÀÌ·ç¾îÁöÁö ¾Ê°í ÀÖÀ¸¸ç, 2030³â±îÁö ȯÀÚ ¼ö°¡ 1,210¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»ó¿¡ µû¶ó Á¶±â, Àúħ½ÀÀû Áø´Ü ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ½À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå : ½Ã¼ú À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¹Ì±¹ÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå : Á¦Ç° ¹üÀ§ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. Electrophysiology Mapping and Ablation Devices Market Summary

The U.S. electrophysiology mapping and ablation devices market size was estimated at USD 10.47 billion in 2024 and is projected to reach USD 23.11 billion by 2033, growing at a CAGR of 8.05% from 2025 to 2033. Widespread use of electrophysiology (EP) mapping and ablation devices in the U.S. is being driven by the escalating burden of atrial fibrillation and other complex arrhythmias, particularly among aging and at-risk populations.

As clinical guidelines increasingly favor early interventional treatment, hospitals and ambulatory centers are expanding their EP capabilities.Rising obesity rates, hypertension, and diabetes prevalence in the U.S. are contributing to increased procedure volumes and accelerating the demand for advanced diagnostic and therapeutic EP technologies. According to the CDC, approximately 12.1 million people in the U.S. will be suffering from atrial fibrillation by 2030. The growing burden of arrhythmias in the U.S., particularly atrial fibrillation, is driving increased adoption of electrophysiology (EP) mapping and ablation devices.

As hospitals and specialty centers expand their cardiac programs, there is a rising demand for tools that enable faster, more accurate diagnosis and targeted treatment. In March 202, Clinical Cardiology published a 25-year analysis of arrhythmia-related deaths in the U.S., reporting 5.05 million deaths among adults aged 35+ from 1999-2023. Mortality fell from 1999 to 2009, then rose steadily, peaking in 2021 during the COVID-19 pandemic before declining slightly.

Technological advancement remains a key driver of market growth. Innovations in 3D mapping systems, pulsed field ablation platforms, and AI-guided navigation are improving precision and reducing procedural risk. These technologies are gaining traction among U.S. providers seeking to streamline workflows, enhance outcomes, and stay ahead in an increasingly competitive electrophysiology landscape. In June 2025, Phillips Medisize launched TheraVolt, its first branded line of medical connectors tailored for high-voltage, high pin-count electrophysiology (EP) mapping and ablation devices. Designed to support pulsed field ablation therapies, TheraVolt offers customizable, sterilization-compatible solutions with high-density integration and platform flexibility.

Growing awareness and screening initiatives across the U.S. are accelerating the use of EP technologies. Community health programs, health system-led outreach, and proactive rhythm monitoring are helping identify arrhythmias earlier. As more patients are diagnosed before complications arise, demand for diagnostic and therapeutic EP procedures and the devices that support them continues to rise. In July 2025, a white paper published by PCNA evaluated the outcomes of a community-based screening initiative targeting atrial fibrillation (AFib) and hypertension in Baltimore, Maryland. The report noted that AFib remains underdiagnosed due to its episodic symptoms, underscoring the growing need for early, minimally invasive diagnostic solutions as cases are projected to rise to 12.1 million by 2030.

U.S. Electrophysiology Mapping And Ablation Devices Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. electrophysiology mapping and ablation devices market report based on procedure type and product coverage:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Electrophysiology Mapping and Ablation Devices Market Variables, Trends & Scope

Chapter 4. U.S. Electrophysiology Mapping and Ablation Devices Market: Procedure Type Estimates & Trend Analysis

Chapter 5. U.S. Electrophysiology Mapping and Ablation Devices Market: Product Coverage Estimates & Trend Analysis

Chapter 6. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â